|
|
Gene Symbol |
FLT1 |
|
Aliases |
FLT, FLT-1, VEGFR-1, VEGFR1 |
|
Entrez Gene ID |
|
|
Gene Name |
Fms related receptor tyrosine kinase 1 |
|
Chromosomal Location |
13q12.3 |
|
HGNC ID |
|
|
Summary |
This gene encodes a member of the vascular endothelial growth factor receptor (VEGFR) family. VEGFR family members are receptor tyrosine kinases (RTKs) which contain an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and a tyrosine kinase (TK) domain within the cytoplasmic domain. This protein binds to VEGFR-A, VEGFR-B and placental growth factor and plays an important role in angiogenesis and vasculogenesis. Expression of this receptor is found in vascular endothelial cells, placental trophoblast cells and peripheral blood monocytes. Multiple transcript variants encoding different isoforms have been found for this gene. Isoforms include a full-length transmembrane receptor isoform and shortened, soluble isoforms. The soluble isoforms are associated with the onset of pre-eclampsia.[provided by RefSeq, May 2009]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0002040 |
Biological process |
Sprouting angiogenesis |
IBA |
21873635 |
GO:0002548 |
Biological process |
Monocyte chemotaxis |
IDA |
8605350, 18079407 |
GO:0007169 |
Biological process |
Transmembrane receptor protein tyrosine kinase signaling pathway |
IBA |
21873635 |
GO:0008284 |
Biological process |
Positive regulation of cell proliferation |
IBA |
21873635 |
GO:0010863 |
Biological process |
Positive regulation of phospholipase C activity |
IMP |
11312102 |
GO:0014068 |
Biological process |
Positive regulation of phosphatidylinositol 3-kinase signaling |
IBA |
21873635 |
GO:0014068 |
Biological process |
Positive regulation of phosphatidylinositol 3-kinase signaling |
IMP |
14633857 |
GO:0016477 |
Biological process |
Cell migration |
IBA |
21873635 |
GO:0016477 |
Biological process |
Cell migration |
IMP |
8605350 |
GO:0018108 |
Biological process |
Peptidyl-tyrosine phosphorylation |
IDA |
9299537, 11513746 |
GO:0030335 |
Biological process |
Positive regulation of cell migration |
IDA |
8605350 |
GO:0030949 |
Biological process |
Positive regulation of vascular endothelial growth factor receptor signaling pathway |
IDA |
1312256 |
GO:0035924 |
Biological process |
Cellular response to vascular endothelial growth factor stimulus |
IDA |
8605350 |
GO:0036323 |
Biological process |
Vascular endothelial growth factor receptor-1 signaling pathway |
IDA |
15952180 |
GO:0043406 |
Biological process |
Positive regulation of MAP kinase activity |
IDA |
9299537 |
GO:0043410 |
Biological process |
Positive regulation of MAPK cascade |
IBA |
21873635 |
GO:0043410 |
Biological process |
Positive regulation of MAPK cascade |
IDA |
9299537 |
GO:0043552 |
Biological process |
Positive regulation of phosphatidylinositol 3-kinase activity |
IMP |
11312102 |
GO:0045766 |
Biological process |
Positive regulation of angiogenesis |
IBA |
21873635 |
GO:0045766 |
Biological process |
Positive regulation of angiogenesis |
IMP |
14633857, 28637396 |
GO:0046777 |
Biological process |
Protein autophosphorylation |
IDA |
9299537, 11513746 |
GO:0048010 |
Biological process |
Vascular endothelial growth factor receptor signaling pathway |
IBA |
21873635 |
GO:0048010 |
Biological process |
Vascular endothelial growth factor receptor signaling pathway |
IDA |
9299537 |
GO:0048010 |
Biological process |
Vascular endothelial growth factor receptor signaling pathway |
IMP |
11312102 |
GO:0070374 |
Biological process |
Positive regulation of ERK1 and ERK2 cascade |
IBA |
21873635 |
GO:1905563 |
Biological process |
Negative regulation of vascular endothelial cell proliferation |
IGI |
22955733 |
GO:0005615 |
Cellular component |
Extracellular space |
TAS |
8248162 |
GO:0005887 |
Cellular component |
Integral component of plasma membrane |
IBA |
21873635 |
GO:0005887 |
Cellular component |
Integral component of plasma membrane |
IDA |
11513746 |
GO:0005925 |
Cellular component |
Focal adhesion |
HDA |
21423176 |
GO:0043235 |
Cellular component |
Receptor complex |
IBA |
21873635 |
GO:0043235 |
Cellular component |
Receptor complex |
IDA |
23382219 |
GO:0004714 |
Molecular function |
Transmembrane receptor protein tyrosine kinase activity |
IBA |
21873635 |
GO:0005021 |
Molecular function |
Vascular endothelial growth factor-activated receptor activity |
IBA |
21873635 |
GO:0005021 |
Molecular function |
Vascular endothelial growth factor-activated receptor activity |
IDA |
1312256, 9299537 |
GO:0005021 |
Molecular function |
Vascular endothelial growth factor-activated receptor activity |
IMP |
11312102 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
1312256, 7657594, 9393862, 10543948, 12771128, 14684734, 16893970, 18273061, 20660291, 23397142 |
GO:0019838 |
Molecular function |
Growth factor binding |
IPI |
1312256, 10471394, 11513746, 12366396, 16109918 |
GO:0036326 |
Molecular function |
VEGF-A-activated receptor activity |
IDA |
8605350 |
GO:0036327 |
Molecular function |
VEGF-B-activated receptor activity |
IDA |
15952180 |
GO:0036332 |
Molecular function |
Placental growth factor-activated receptor activity |
IDA |
12796773 |
GO:0038085 |
Molecular function |
Vascular endothelial growth factor binding |
IBA |
21873635 |
|
Protein Information |
|
Protein Name |
Vascular endothelial growth factor receptor 1, fms related tyrosine kinase 1, fms-like tyrosine kinase 1, fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor), tyrosine-protein kinase FRT, tyrosine-protein kinase receptor FLT, vascular permeability factor receptor |
|
Function |
|
|
|
|
|
UniProt |
|
|
PDB |
1RV6, 5EX3, 1FLT, 1QTY, 5T89, 2XAC, 1QSV, 1QSZ, 3HNG, 4CKV, 4CL7, 5ABD |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000384364 |
P01303 |
P01303 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Arteriosclerosis |
|
Ischemic Cardiomyopathy |
|
Coronary heart disease |
|
Myocardial Infarction |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Skeletal Dysplasia |
|
Van Buchem disease |
|
Melnick-Needles Syndrome |
|
Schwartz-Jampel Syndrome |
|
Digestive System Diseases |
Liver Diseases |
|
Liver Cirrhosis |
|
Hepatitis |
|
Liver Fibrosis |
|
Endocrine System Diseases |
PCOS |
|
Neoplasms |
Breast Cancer |
|
Renal Cancer |
|
Skin Cancer |
|
Hemangioma |
|
Nutritional and Metabolic Diseases |
Gluocose Intolerance |
|
Psychiatric/Brain disorders |
Obstructive Sleep Apnea |
|
Renal Disorder |
Uremia |
|
Reproductive disorders |
Preeclampsia |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
|
|
|
|
Direct
|
|
This review concluded that VEGF may have a strategic role in the pathophysiology of PCOS and is the key mediator in the pathogenesis of ovarian hyperstimulation syndrome (OHSS) in women undergoing assisted reproductive procedures. Its role is perhaps not singular and several other factors such as the bioavailability of its soluble receptor sFlt-1 and a multidisciplinary orchestration of other cytokines and growth factors may be involved in the pathophysiology of PCOS and OHSS. |
|
|
|